Meridian Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-8,886
Closed -$2.1M 73
2019
Q1
$2.1M Sell
8,886
-90
-1% -$28.3K 1.04% 32
2018
Q4
$2.7M Sell
8,976
-100
-1% -$31.9K 1.38% 16
2018
Q3
$3.21M Sell
9,076
-75
-0.8% -$25.8K 1.4% 17
2018
Q2
$2.66M Buy
9,151
+85
+0.9% +$23.9K 1.23% 23
2018
Q1
$2.48M Buy
9,066
+35
+0.4% +$10.9K 1.15% 25
2017
Q4
$2.88M Sell
9,031
-220
-2% -$70.6K 1.34% 18
2017
Q3
$2.9M Hold
9,251
1.43% 17
2017
Q2
$2.51M Buy
9,251
+1,075
+13% +$284K 1.32% 19
2017
Q1
$2.23M Sell
8,176
-1,377
-14% -$389K 1.27% 25
2016
Q4
$2.71M Sell
9,553
-1,155
-11% -$342K 1.6% 21
2016
Q3
$3.35M Sell
10,708
-521
-5% -$154K 1.93% 13
2016
Q2
$2.71M Buy
11,229
+5,203
+86% +$1.37M 1.65% 22
2016
Q1
$1.57M Buy
6,026
+310
+5% +$81.9K 0.96% 41
2015
Q4
$1.75M Hold
5,716
1.12% 35
2015
Q3
$1.67M Buy
+5,716
New +$1.89M 1.09% 34

Other funds holding BIIB

Meridian Management's BIIB Position: Q2 2019 in Review

Meridian Management sold out of Biogen (BIIB) in Q2 2019, closing a stake of 8,886 shares — an estimated $2.1M sold.

Meridian Management first reported a position in BIIB in Q3 2015 and held it in 15 quarters. The position peaked at $3.35M in Q3 2016. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Meridian Management reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Meridian Management sold 8,886 Biogen shares in Q2 2019, an estimated $2.1M.
  • Meridian Management first reported a position in Biogen in Q3 2015 and held it in 15 quarters.
  • Meridian Management's Biogen position peaked at $3.35M in Q3 2016.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Meridian Management's 13F filing for Q2 2019, filed 5 Aug 2019.